25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Sinil Pharmaceutical Co. Ltd
Buy, Hold or Sell?

Let's analyze Sinil Pharmaceutical Co. Ltd together

I guess you are interested in Sinil Pharmaceutical Co. Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sinil Pharmaceutical Co. Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Sinil Pharmaceutical Co. Ltd

I send you an email if I find something interesting about Sinil Pharmaceutical Co. Ltd.

1. Quick Overview

1.1. Quick analysis of Sinil Pharmaceutical Co. Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Sinil Pharmaceutical Co. Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₩0.07
When do you have the money?
1 year
How often do you get paid?
86.2%

What is your share worth?

Current worth
₩12,158.39
Expected worth in 1 year
₩13,279.54
How sure are you?
93.1%

+ What do you gain per year?

Total Gains per Share
₩1,217.38
Return On Investment
18.6%

For what price can you sell your share?

Current Price per Share
₩6,550.00
Expected price per share
₩5,920 - ₩6,740
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Sinil Pharmaceutical Co. Ltd (5 min.)




Live pricePrice per Share (EOD)
₩6,550.00

2.2. Growth of Sinil Pharmaceutical Co. Ltd (5 min.)




Is Sinil Pharmaceutical Co. Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$98.3m$87m$8m8.4%

How much money is Sinil Pharmaceutical Co. Ltd making?

Current yearPrevious yearGrowGrow %
Making money$2.7m$2m$726.1k26.3%
Net Profit Margin16.4%14.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Sinil Pharmaceutical Co. Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Sinil Pharmaceutical Co. Ltd?

Welcome investor! Sinil Pharmaceutical Co. Ltd's management wants to use your money to grow the business. In return you get a share of Sinil Pharmaceutical Co. Ltd.

First you should know what it really means to hold a share of Sinil Pharmaceutical Co. Ltd. And how you can make/lose money.

Speculation

The Price per Share of Sinil Pharmaceutical Co. Ltd is ₩6,550. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sinil Pharmaceutical Co. Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sinil Pharmaceutical Co. Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩12,158.39. Based on the TTM, the Book Value Change Per Share is ₩280.29 per quarter. Based on the YOY, the Book Value Change Per Share is ₩208.28 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩24.06 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sinil Pharmaceutical Co. Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.240.0%0.240.0%0.110.0%0.140.0%0.130.0%
Usd Book Value Change Per Share0.240.0%0.200.0%0.150.0%0.130.0%0.290.0%
Usd Dividend Per Share0.000.0%0.020.0%0.070.0%0.050.0%0.050.0%
Usd Total Gains Per Share0.240.0%0.210.0%0.210.0%0.180.0%0.350.0%
Usd Price Per Share5.15-5.11-5.70-7.91-8.03-
Price to Earnings Ratio5.38-5.40-12.83-18.10--15.11-
Price-to-Total Gains Ratio21.52-27.98-27.21-53.78-58.38-
Price to Book Ratio0.61-0.62-0.76-1.16-1.90-
Price-to-Total Gains Ratio21.52-27.98-27.21-53.78-58.38-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.585
Number of shares218
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.05
Usd Book Value Change Per Share0.200.13
Usd Total Gains Per Share0.210.18
Gains per Quarter (218 shares)46.4439.66
Gains per Year (218 shares)185.77158.65
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11517117646113149
22934236292226308
344513548138338467
459684734183451626
573855920229564785
68810271106275677944
7103119812923217891103
8117136914783679021262
91321540166441310151421
101471711185045911281580

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%28.01.00.096.6%28.01.00.096.6%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%25.04.00.086.2%25.04.00.086.2%
Dividend per Share1.00.03.025.0%8.00.04.066.7%16.00.04.080.0%25.00.04.086.2%25.00.04.086.2%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%27.02.00.093.1%27.02.00.093.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Sinil Pharmaceutical Co. Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--342.031280.286+22%208.277+64%184.764+85%419.255-18%
Book Value Per Share--12158.39411745.394+4%10753.795+13%10095.270+20%9110.723+33%
Current Ratio--5.0374.695+7%4.245+19%4.711+7%5.229-4%
Debt To Asset Ratio--0.1110.120-7%0.135-18%0.133-16%0.124-11%
Debt To Equity Ratio--0.1250.136-8%0.156-20%0.153-18%0.142-12%
Dividend Per Share---24.057-100%96.211-100%75.145-100%75.892-100%
Enterprise Value--67483215000.00070435867580.000-4%95770439786.563-30%128257132878.340-47%189788468751.562-64%
Eps--342.031340.907+0%163.143+110%203.829+68%184.879+85%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--0.6890.729-6%1.182-42%1.883-63%3.284-79%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap75715380000.000-12%85078656000.00084413979000.000+1%94200074721.563-10%130716758995.840-35%194952327228.803-56%
Net Profit Margin--0.1610.164-1%0.141+15%0.133+21%0.131+23%
Operating Margin----0%0.052-100%0.057-100%0.082-100%
Operating Ratio--1.0971.329-17%1.198-8%0.947+16%1.104-1%
Pb Ratio0.539-12%0.6050.622-3%0.758-20%1.157-48%1.903-68%
Pe Ratio4.788-12%5.3805.4000%12.831-58%18.096-70%-15.107+381%
Price Per Share6550.000-12%7360.0007302.500+1%8147.500-10%11307.000-35%11467.241-36%
Price To Free Cash Flow Ratio---0.138-100%3.754-100%11.065-100%15.341-100%
Price To Total Gains Ratio19.150-12%21.51927.979-23%27.212-21%53.779-60%58.382-63%
Quick Ratio---2.237-100%3.961-100%3.795-100%3.896-100%
Return On Assets--0.0250.026-2%0.020+24%0.019+34%0.018+40%
Return On Equity--0.0280.029-3%0.023+20%0.021+31%0.020+37%
Total Gains Per Share--342.031304.344+12%304.488+12%259.908+32%495.147-31%
Usd Book Value--98382319.70095040435.513+4%87033362.208+13%81697860.590+20%76758585.705+28%
Usd Book Value Change Per Share--0.2390.196+22%0.146+64%0.129+85%0.293-18%
Usd Book Value Per Share--8.5118.222+4%7.528+13%7.067+20%6.378+33%
Usd Dividend Per Share---0.017-100%0.067-100%0.053-100%0.053-100%
Usd Enterprise Value--47238250.50049305107.306-4%67039307.851-30%89779993.015-47%132851928.126-64%
Usd Eps--0.2390.239+0%0.114+110%0.143+68%0.129+85%
Usd Free Cash Flow---1883921.680-100%-892778.5090%895812.659-100%322287.929-100%
Usd Market Cap53000766.000-12%59555059.20059089785.300+1%65940052.305-10%91501731.297-35%136466629.060-56%
Usd Price Per Share4.585-12%5.1525.112+1%5.703-10%7.915-35%8.027-36%
Usd Profit--2767619.4002758520.263+0%2032345.709+36%1791943.920+54%1606976.823+72%
Usd Revenue--17150279.30016890270.899+2%14203467.726+21%13048297.113+31%11885327.062+44%
Usd Total Gains Per Share--0.2390.213+12%0.213+12%0.182+32%0.347-31%
 EOD+3 -4MRQTTM+21 -12YOY+22 -115Y+21 -1310Y+16 -18

3.3 Fundamental Score

Let's check the fundamental score of Sinil Pharmaceutical Co. Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-154.788
Price to Book Ratio (EOD)Between0-10.539
Net Profit Margin (MRQ)Greater than00.161
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than15.037
Debt to Asset Ratio (MRQ)Less than10.111
Debt to Equity Ratio (MRQ)Less than10.125
Return on Equity (MRQ)Greater than0.150.028
Return on Assets (MRQ)Greater than0.050.025
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Sinil Pharmaceutical Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.601
Ma 20Greater thanMa 506,493.000
Ma 50Greater thanMa 1006,901.400
Ma 100Greater thanMa 2007,215.300
OpenGreater thanClose6,550.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Sinil Pharmaceutical Co. Ltd

Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers pharmaceutical products for various indications, such as pain reliever, anti-inflammatory, hyperlipidemia, skin disease, and folic acid deficiency; and general/specialty drugs, veterinary drugs, and OEM products for various diseases. The company also provides cosmetics, including skin care products, etc.; health functional products comprising vitamin supplements; and quasi-drugs for yellow dust, bacteria blocking, etc. In addition, it is involved in the real estate rental services. The company was founded in 1971 and is headquartered in Chungju-si, South Korea.

Fundamental data was last updated by Penke on 2024-12-09 09:30:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Sinil Pharmaceutical Co. Ltd earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Sinil Pharmaceutical Co. Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 16.1% means that ₩0.16 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sinil Pharmaceutical Co. Ltd:

  • The MRQ is 16.1%. The company is making a huge profit. +2
  • The TTM is 16.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ16.1%TTM16.4%-0.2%
TTM16.4%YOY14.1%+2.3%
TTM16.4%5Y13.3%+3.1%
5Y13.3%10Y13.1%+0.2%
4.3.1.2. Return on Assets

Shows how efficient Sinil Pharmaceutical Co. Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sinil Pharmaceutical Co. Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.5% Return on Assets means that Sinil Pharmaceutical Co. Ltd generated ₩0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sinil Pharmaceutical Co. Ltd:

  • The MRQ is 2.5%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.6%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.5%TTM2.6%-0.1%
TTM2.6%YOY2.0%+0.5%
TTM2.6%5Y1.9%+0.7%
5Y1.9%10Y1.8%+0.1%
4.3.1.3. Return on Equity

Shows how efficient Sinil Pharmaceutical Co. Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sinil Pharmaceutical Co. Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.8% Return on Equity means Sinil Pharmaceutical Co. Ltd generated ₩0.03 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sinil Pharmaceutical Co. Ltd:

  • The MRQ is 2.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.8%TTM2.9%-0.1%
TTM2.9%YOY2.3%+0.6%
TTM2.9%5Y2.1%+0.8%
5Y2.1%10Y2.0%+0.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Sinil Pharmaceutical Co. Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Sinil Pharmaceutical Co. Ltd is operating .

  • Measures how much profit Sinil Pharmaceutical Co. Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sinil Pharmaceutical Co. Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sinil Pharmaceutical Co. Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY5.2%-5.2%
TTM-5Y5.7%-5.7%
5Y5.7%10Y8.2%-2.5%
4.3.2.2. Operating Ratio

Measures how efficient Sinil Pharmaceutical Co. Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.10 means that the operating costs are ₩1.10 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Sinil Pharmaceutical Co. Ltd:

  • The MRQ is 1.097. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.329. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.097TTM1.329-0.232
TTM1.329YOY1.198+0.131
TTM1.3295Y0.947+0.382
5Y0.94710Y1.104-0.157
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Sinil Pharmaceutical Co. Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Sinil Pharmaceutical Co. Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 5.04 means the company has ₩5.04 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Sinil Pharmaceutical Co. Ltd:

  • The MRQ is 5.037. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.695. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.037TTM4.695+0.342
TTM4.695YOY4.245+0.450
TTM4.6955Y4.711-0.016
5Y4.71110Y5.229-0.518
4.4.3.2. Quick Ratio

Measures if Sinil Pharmaceutical Co. Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sinil Pharmaceutical Co. Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sinil Pharmaceutical Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.237-2.237
TTM2.237YOY3.961-1.724
TTM2.2375Y3.795-1.558
5Y3.79510Y3.896-0.100
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Sinil Pharmaceutical Co. Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Sinil Pharmaceutical Co. Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sinil Pharmaceutical Co. Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.11 means that Sinil Pharmaceutical Co. Ltd assets are financed with 11.1% credit (debt) and the remaining percentage (100% - 11.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sinil Pharmaceutical Co. Ltd:

  • The MRQ is 0.111. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.120. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.111TTM0.120-0.008
TTM0.120YOY0.135-0.015
TTM0.1205Y0.133-0.013
5Y0.13310Y0.124+0.008
4.5.4.2. Debt to Equity Ratio

Measures if Sinil Pharmaceutical Co. Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sinil Pharmaceutical Co. Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 12.5% means that company has ₩0.13 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sinil Pharmaceutical Co. Ltd:

  • The MRQ is 0.125. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.136. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.125TTM0.136-0.011
TTM0.136YOY0.156-0.020
TTM0.1365Y0.153-0.017
5Y0.15310Y0.142+0.011
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Sinil Pharmaceutical Co. Ltd generates.

  • Above 15 is considered overpriced but always compare Sinil Pharmaceutical Co. Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 5.38 means the investor is paying ₩5.38 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sinil Pharmaceutical Co. Ltd:

  • The EOD is 4.788. Based on the earnings, the company is cheap. +2
  • The MRQ is 5.380. Based on the earnings, the company is cheap. +2
  • The TTM is 5.400. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD4.788MRQ5.380-0.592
MRQ5.380TTM5.400-0.020
TTM5.400YOY12.831-7.432
TTM5.4005Y18.096-12.696
5Y18.09610Y-15.107+33.203
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sinil Pharmaceutical Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.138-0.138
TTM0.138YOY3.754-3.616
TTM0.1385Y11.065-10.927
5Y11.06510Y15.341-4.276
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Sinil Pharmaceutical Co. Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 0.61 means the investor is paying ₩0.61 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Sinil Pharmaceutical Co. Ltd:

  • The EOD is 0.539. Based on the equity, the company is cheap. +2
  • The MRQ is 0.605. Based on the equity, the company is cheap. +2
  • The TTM is 0.622. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.539MRQ0.605-0.067
MRQ0.605TTM0.622-0.016
TTM0.622YOY0.758-0.136
TTM0.6225Y1.157-0.536
5Y1.15710Y1.903-0.745
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets158,141,612
Total Liabilities17,595,441
Total Stockholder Equity140,546,171
 As reported
Total Liabilities 17,595,441
Total Stockholder Equity+ 140,546,171
Total Assets = 158,141,612

Assets

Total Assets158,141,612
Total Current Assets71,804,683
Long-term Assets86,336,929
Total Current Assets
Total Current Assets  (as reported)71,804,683
Total Current Assets  (calculated)0
+/- 71,804,683
Long-term Assets
Long-term Assets  (as reported)86,336,929
Long-term Assets  (calculated)0
+/- 86,336,929

Liabilities & Shareholders' Equity

Total Current Liabilities14,256,445
Long-term Liabilities3,338,996
Total Stockholder Equity140,546,171
Total Current Liabilities
Total Current Liabilities  (as reported)14,256,445
Total Current Liabilities  (calculated)0
+/- 14,256,445
Long-term Liabilities
Long-term Liabilities  (as reported)3,338,996
Long-term Liabilities  (calculated)0
+/- 3,338,996
Total Stockholder Equity
Total Stockholder Equity (as reported)140,546,171
Total Stockholder Equity (calculated)0
+/- 140,546,171
Other
Common Stock Shares Outstanding 11,560
Net Working Capital 57,548,238



6.2. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
> Total Assets 
100,958,824
101,683,437
102,521,018
106,316,582
104,068,534
105,772,479
106,403,889
107,965,950
110,642,623
114,047,729
117,837,501
121,193,540
123,137,780
124,684,482
124,809,785
125,142,298
123,041,558
126,074,814
128,973,567
133,239,936
135,294,834
138,616,516
142,831,660
146,775,081
146,784,479
148,935,940
152,459,585
157,425,523
158,141,612
158,141,612157,425,523152,459,585148,935,940146,784,479146,775,081142,831,660138,616,516135,294,834133,239,936128,973,567126,074,814123,041,558125,142,298124,809,785124,684,482123,137,780121,193,540117,837,501114,047,729110,642,623107,965,950106,403,889105,772,479104,068,534106,316,582102,521,018101,683,437100,958,824
   > Total Current Assets 
46,908,439
44,943,588
47,637,195
49,871,945
50,458,911
50,803,404
47,021,624
46,771,144
47,657,043
48,754,843
50,666,665
53,676,460
55,023,382
53,846,135
52,772,239
53,114,435
51,876,326
54,421,220
58,426,607
62,403,431
63,486,044
64,632,617
67,279,974
67,798,724
64,217,476
65,261,163
68,787,350
71,824,703
71,804,683
71,804,68371,824,70368,787,35065,261,16364,217,47667,798,72467,279,97464,632,61763,486,04462,403,43158,426,60754,421,22051,876,32653,114,43552,772,23953,846,13555,023,38253,676,46050,666,66548,754,84347,657,04346,771,14447,021,62450,803,40450,458,91149,871,94547,637,19544,943,58846,908,439
       Cash And Cash Equivalents 
1,142,080
772,767
2,262,449
3,292,096
2,510,063
4,934,892
1,727,044
1,695,549
2,565,117
2,638,131
2,948,092
4,623,887
6,706,948
2,838,398
4,144,264
5,707,528
4,366,421
7,109,419
29,868
47,808
30,410
32,846
38,928
70,408
79,148
81,088
7,519,305
7,161,232
0
07,161,2327,519,30581,08879,14870,40838,92832,84630,41047,80829,8687,109,4194,366,4215,707,5284,144,2642,838,3986,706,9484,623,8872,948,0922,638,1312,565,1171,695,5491,727,0444,934,8922,510,0633,292,0962,262,449772,7671,142,080
       Short-term Investments 
11,579,284
10,002,809
11,016,586
12,139,041
13,139,041
12,134,750
11,954,480
10,068,900
10,078,400
10,050,650
10,607,800
0
0
10,280,000
10,430,000
10,580,000
11,230,000
11,380,000
13,530,000
14,730,000
15,860,000
18,410,000
18,410,000
18,410,000
14,500,000
14,500,000
15,900,000
19,740,000
0
019,740,00015,900,00014,500,00014,500,00018,410,00018,410,00018,410,00015,860,00014,730,00013,530,00011,380,00011,230,00010,580,00010,430,00010,280,0000010,607,80010,050,65010,078,40010,068,90011,954,48012,134,75013,139,04112,139,04111,016,58610,002,80911,579,284
       Net Receivables 
18,784,664
19,447,795
19,969,067
18,932,487
20,193,087
19,179,477
19,870,448
20,187,734
20,097,897
20,154,117
21,968,778
21,895,153
20,699,481
22,118,608
21,192,473
19,300,889
20,097,002
21,068,605
20,684,160
20,214,048
22,267,020
22,851,688
23,576,939
24,122,923
21,694,598
21,753,770
21,877,686
21,519,401
0
021,519,40121,877,68621,753,77021,694,59824,122,92323,576,93922,851,68822,267,02020,214,04820,684,16021,068,60520,097,00219,300,88921,192,47322,118,60820,699,48121,895,15321,968,77820,154,11720,097,89720,187,73419,870,44819,179,47720,193,08718,932,48719,969,06719,447,79518,784,664
       Inventory 
11,571,966
12,280,499
13,417,681
13,886,978
13,163,386
13,877,764
13,393,087
14,778,530
14,841,123
15,297,278
15,071,708
16,583,510
17,451,452
18,555,365
16,937,112
17,363,330
16,116,343
14,822,355
16,700,262
18,415,775
17,865,407
18,386,366
20,187,523
23,064,754
25,798,539
25,274,249
22,491,724
22,364,682
0
022,364,68222,491,72425,274,24925,798,53923,064,75420,187,52318,386,36617,865,40718,415,77516,700,26214,822,35516,116,34317,363,33016,937,11218,555,36517,451,45216,583,51015,071,70815,297,27814,841,12314,778,53013,393,08713,877,76413,163,38613,886,97813,417,68112,280,49911,571,966
       Other Current Assets 
3,820,319
2,433,954
941,192
1,596,777
1,437,313
670,348
48,215
16,700
59,059
238,175
18,539
3,606
201
31,725
26,312
91,851
36,089
10,750
0
0
0
38,919
0
0
1,160
0
0
0
0
00001,1600038,91900010,75036,08991,85126,31231,7252013,60618,539238,17559,05916,70048,215670,3481,437,3131,596,777941,1922,433,9543,820,319
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
75,551,686
78,976,357
82,567,003
83,674,778
83,672,235
85,600,819
86,336,929
86,336,92985,600,81983,672,23583,674,77882,567,00378,976,35775,551,6860000000000000000000000
       Property Plant Equipment 
23,082,382
26,061,236
25,269,579
25,199,442
24,056,768
23,652,410
24,288,888
25,665,767
27,543,302
27,672,393
28,004,606
27,916,772
28,566,687
31,290,710
32,150,480
31,941,115
31,281,780
31,586,315
30,999,083
31,290,511
32,191,524
33,308,213
35,743,878
38,801,896
40,901,484
41,880,017
41,916,318
43,731,300
0
043,731,30041,916,31841,880,01740,901,48438,801,89635,743,87833,308,21332,191,52431,290,51130,999,08331,586,31531,281,78031,941,11532,150,48031,290,71028,566,68727,916,77228,004,60627,672,39327,543,30225,665,76724,288,88823,652,41024,056,76825,199,44225,269,57926,061,23623,082,382
       Long Term Investments 
212,861
212,861
185,020
172,490
168,940
75,440
34,369
34,370
18,705
1,518,818
1,515,387
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000001,515,3871,518,81818,70534,37034,36975,440168,940172,490185,020212,861212,861
       Intangible Assets 
1,598,907
1,598,576
1,222,914
1,219,708
1,216,500
1,158,332
1,155,175
1,152,206
1,154,788
1,152,806
1,135,170
1,132,245
1,129,360
1,126,585
1,319,965
1,537,282
1,700,342
1,758,973
1,801,133
1,847,907
1,926,731
1,943,617
1,870,060
1,857,788
1,867,915
1,844,643
1,810,170
1,782,698
0
01,782,6981,810,1701,844,6431,867,9151,857,7881,870,0601,943,6171,926,7311,847,9071,801,1331,758,9731,700,3421,537,2821,319,9651,126,5851,129,3601,132,2451,135,1701,152,8061,154,7881,152,2061,155,1751,158,3321,216,5001,219,7081,222,9141,598,5761,598,907
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
1
0
0
0
0001-1000000000000000000000000
> Total Liabilities 
10,595,725
9,783,270
11,590,062
11,719,003
10,275,079
9,984,907
11,219,151
12,579,836
12,812,340
14,564,560
16,592,756
19,068,878
18,513,777
18,121,039
17,325,748
17,747,332
14,402,331
15,701,928
15,777,446
18,613,340
17,245,800
18,110,075
19,554,353
20,811,511
19,198,298
17,881,365
17,564,557
20,833,094
17,595,441
17,595,44120,833,09417,564,55717,881,36519,198,29820,811,51119,554,35318,110,07517,245,80018,613,34015,777,44615,701,92814,402,33117,747,33217,325,74818,121,03918,513,77719,068,87816,592,75614,564,56012,812,34012,579,83611,219,1519,984,90710,275,07911,719,00311,590,0629,783,27010,595,725
   > Total Current Liabilities 
6,453,989
6,845,853
8,268,590
9,084,221
7,341,570
6,841,190
7,403,428
8,327,932
7,850,532
9,250,869
11,078,091
13,069,269
12,332,011
11,650,804
10,386,729
10,703,340
8,614,559
9,782,650
12,023,112
14,773,529
13,477,479
14,057,184
15,958,952
16,948,742
15,414,600
14,216,052
14,144,528
16,745,913
14,256,445
14,256,44516,745,91314,144,52814,216,05215,414,60016,948,74215,958,95214,057,18413,477,47914,773,52912,023,1129,782,6508,614,55910,703,34010,386,72911,650,80412,332,01113,069,26911,078,0919,250,8697,850,5328,327,9327,403,4286,841,1907,341,5709,084,2218,268,5906,845,8536,453,989
       Short-term Debt 
437,019
383,650
310,884
362,932
300,788
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000300,788362,932310,884383,650437,019
       Short Long Term Debt 
437,019
383,650
310,884
362,932
300,788
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000300,788362,932310,884383,650437,019
       Accounts payable 
1,963,957
2,979,687
3,462,836
2,649,480
2,639,191
2,759,987
2,762,140
3,192,712
3,185,145
3,942,852
4,044,204
4,562,682
4,904,141
3,785,401
3,756,151
2,677,572
2,616,744
2,861,867
0
0
0
5,512,346
6,806,508
5,440,461
8,614,283
5,963,665
5,455,008
4,769,538
0
04,769,5385,455,0085,963,6658,614,2835,440,4616,806,5085,512,3460002,861,8672,616,7442,677,5723,756,1513,785,4014,904,1414,562,6824,044,2043,942,8523,185,1453,192,7122,762,1402,759,9872,639,1912,649,4803,462,8362,979,6871,963,957
       Other Current Liabilities 
3,769,402
3,197,093
4,207,636
5,782,533
4,110,275
3,579,389
4,345,891
4,833,158
4,232,307
4,883,889
5,633,640
7,274,021
6,263,482
6,742,950
5,627,615
7,026,278
5,011,521
5,924,365
0
0
0
7,595,000
0
0
5,782,850
0
0
1
0
01005,782,850007,595,0000005,924,3655,011,5217,026,2785,627,6156,742,9506,263,4827,274,0215,633,6404,883,8894,232,3074,833,1584,345,8913,579,3894,110,2755,782,5334,207,6363,197,0933,769,402
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,595,402
3,862,768
3,783,698
3,665,314
3,420,029
4,087,180
3,338,996
3,338,9964,087,1803,420,0293,665,3143,783,6983,862,7683,595,4020000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
423,876
392,953
361,807
330,436
298,838
267,012
234,955
202,667
173,273
139,478
105,442
71,163
37,691
3,977
1,595
33,679
41,239
0
0
0
00041,23933,6791,5953,97737,69171,163105,442139,478173,273202,667234,955267,012298,838330,436361,807392,953423,876000000000
       Capital Lease Obligations Min Short Term Debt
-437,019
-383,650
-310,884
-362,932
-300,788
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
139,478
105,442
117,132
94,916
544,127
507,491
0
0507,491544,12794,916117,132105,442139,47800000000000000000-300,788-362,932-310,884-383,650-437,019
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,196
0
0
0
0
0
0
0
000000010,196000000000000000000000
       Deferred Long Term Liability 
2,637,502
2,635,911
1,841,924
1,838,732
1,809,723
1,800,278
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000001,800,2781,809,7231,838,7321,841,9242,635,9112,637,502
> Total Stockholder Equity
90,363,100
91,900,167
90,930,956
94,597,579
93,793,455
95,787,572
95,184,738
95,386,114
97,830,283
99,483,169
101,244,744
102,124,662
104,624,003
106,563,443
107,484,037
107,394,966
108,639,227
110,372,886
113,196,121
114,626,596
118,049,033
120,506,441
123,277,307
125,963,570
127,586,181
131,054,575
134,895,027
136,592,428
140,546,171
140,546,171136,592,428134,895,027131,054,575127,586,181125,963,570123,277,307120,506,441118,049,033114,626,596113,196,121110,372,886108,639,227107,394,966107,484,037106,563,443104,624,003102,124,662101,244,74499,483,16997,830,28395,386,11495,184,73895,787,57293,793,45594,597,57990,930,95691,900,16790,363,100
   Common Stock
3,950,000
3,950,000
3,950,000
3,950,000
3,950,000
3,950,000
3,950,000
3,950,000
3,950,000
3,950,000
3,950,000
5,451,000
5,451,000
5,451,000
5,451,000
5,451,000
5,608,593
5,608,593
5,608,593
5,608,593
5,770,732
5,770,732
5,770,732
5,770,732
5,993,208
5,993,208
0
0
0
0005,993,2085,993,2085,770,7325,770,7325,770,7325,770,7325,608,5935,608,5935,608,5935,608,5935,451,0005,451,0005,451,0005,451,0005,451,0003,950,0003,950,0003,950,0003,950,0003,950,0003,950,0003,950,0003,950,0003,950,0003,950,0003,950,000
   Retained Earnings 
86,218,044
87,755,112
86,890,168
90,556,792
89,752,668
91,746,784
91,553,315
91,754,691
94,198,859
92,933,307
94,694,882
95,581,063
98,080,405
100,019,845
100,940,439
100,693,775
102,106,463
103,840,122
106,663,357
107,931,693
111,458,617
113,916,025
117,117,910
119,581,698
121,277,703
124,746,098
128,687,519
130,384,920
0
0130,384,920128,687,519124,746,098121,277,703119,581,698117,117,910113,916,025111,458,617107,931,693106,663,357103,840,122102,106,463100,693,775100,940,439100,019,84598,080,40595,581,06394,694,88292,933,30794,198,85991,754,69191,553,31591,746,78489,752,66890,556,79286,890,16887,755,11286,218,044
   Accumulated Other Comprehensive Income 00000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
3,605,273
3,605,273
2,104,273
2,104,273
2,104,273
2,104,273
2,104,273
2,104,273
2,104,273
2,104,273
1,170,000
2,104,273
1,170,000
2,104,273
2,104,273
2,104,273
2,104,273
0
0
0
0002,104,2732,104,2732,104,2732,104,2731,170,0002,104,2731,170,0002,104,2732,104,2732,104,2732,104,2732,104,2732,104,2732,104,2732,104,2733,605,2733,605,273000000000
   Treasury Stock0000000000-1,180,102-1,180,102-1,180,102-1,011,675-1,011,675-1,011,675-1,011,675-1,011,675-1,005,411-1,005,411000000000



6.3. Balance Sheets

Currency in KRW. All numbers in thousands.




6.4. Cash Flows

Currency in KRW. All numbers in thousands.




6.5. Income Statements

Currency in KRW. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue89,135,209
Cost of Revenue-51,564,728
Gross Profit37,570,48137,570,481
 
Operating Income (+$)
Gross Profit37,570,481
Operating Expense-75,143,907
Operating Income13,991,301-37,573,427
 
Operating Expense (+$)
Research Development2,978,753
Selling General Administrative8,158,978
Selling And Marketing Expenses0
Operating Expense75,143,90711,137,731
 
Net Interest Income (+$)
Interest Income849,134
Interest Expense-26,131
Other Finance Cost-0
Net Interest Income823,004
 
Pretax Income (+$)
Operating Income13,991,301
Net Interest Income823,004
Other Non-Operating Income Expenses0
Income Before Tax (EBT)14,953,21013,991,301
EBIT - interestExpense = -26,131
13,641,351
13,667,482
Interest Expense26,131
Earnings Before Interest and Taxes (EBIT)014,979,341
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax14,953,210
Tax Provision-1,311,859
Net Income From Continuing Ops13,641,35113,641,351
Net Income13,641,351
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-823,004
 

Technical Analysis of Sinil Pharmaceutical Co. Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sinil Pharmaceutical Co. Ltd. The general trend of Sinil Pharmaceutical Co. Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sinil Pharmaceutical Co. Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sinil Pharmaceutical Co. Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 6,690 < 6,690 < 6,740.

The bearish price targets are: 5,920.

Tweet this
Sinil Pharmaceutical Co. Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sinil Pharmaceutical Co. Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sinil Pharmaceutical Co. Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sinil Pharmaceutical Co. Ltd. The current macd is -117.41825612.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sinil Pharmaceutical Co. Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Sinil Pharmaceutical Co. Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Sinil Pharmaceutical Co. Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Sinil Pharmaceutical Co. Ltd Daily Moving Average Convergence/Divergence (MACD) ChartSinil Pharmaceutical Co. Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sinil Pharmaceutical Co. Ltd. The current adx is 31.88.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Sinil Pharmaceutical Co. Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Sinil Pharmaceutical Co. Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sinil Pharmaceutical Co. Ltd. The current sar is 6,029.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Sinil Pharmaceutical Co. Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sinil Pharmaceutical Co. Ltd. The current rsi is 47.60. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Sinil Pharmaceutical Co. Ltd Daily Relative Strength Index (RSI) ChartSinil Pharmaceutical Co. Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sinil Pharmaceutical Co. Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Sinil Pharmaceutical Co. Ltd price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Sinil Pharmaceutical Co. Ltd Daily Stochastic Oscillator ChartSinil Pharmaceutical Co. Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sinil Pharmaceutical Co. Ltd. The current cci is 24.83.

Sinil Pharmaceutical Co. Ltd Daily Commodity Channel Index (CCI) ChartSinil Pharmaceutical Co. Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sinil Pharmaceutical Co. Ltd. The current cmo is 6.07465812.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Sinil Pharmaceutical Co. Ltd Daily Chande Momentum Oscillator (CMO) ChartSinil Pharmaceutical Co. Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sinil Pharmaceutical Co. Ltd. The current willr is -18.18181818.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Sinil Pharmaceutical Co. Ltd Daily Williams %R ChartSinil Pharmaceutical Co. Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sinil Pharmaceutical Co. Ltd.

Sinil Pharmaceutical Co. Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sinil Pharmaceutical Co. Ltd. The current atr is 168.52.

Sinil Pharmaceutical Co. Ltd Daily Average True Range (ATR) ChartSinil Pharmaceutical Co. Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sinil Pharmaceutical Co. Ltd. The current obv is 1,953,141.

Sinil Pharmaceutical Co. Ltd Daily On-Balance Volume (OBV) ChartSinil Pharmaceutical Co. Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sinil Pharmaceutical Co. Ltd. The current mfi is 34.77.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Sinil Pharmaceutical Co. Ltd Daily Money Flow Index (MFI) ChartSinil Pharmaceutical Co. Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sinil Pharmaceutical Co. Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-14STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-16STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-08-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-06MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-09MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-03RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-12-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-09STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Sinil Pharmaceutical Co. Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sinil Pharmaceutical Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.601
Ma 20Greater thanMa 506,493.000
Ma 50Greater thanMa 1006,901.400
Ma 100Greater thanMa 2007,215.300
OpenGreater thanClose6,550.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Sinil Pharmaceutical Co. Ltd with someone you think should read this too:
  • Are you bullish or bearish on Sinil Pharmaceutical Co. Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sinil Pharmaceutical Co. Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sinil Pharmaceutical Co. Ltd

I send you an email if I find something interesting about Sinil Pharmaceutical Co. Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Sinil Pharmaceutical Co. Ltd.

Receive notifications about Sinil Pharmaceutical Co. Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.